In a groundbreaking development, the recent trials of a drug developed by Ireland-based psychedelics biotech company GH Research have showcased its potential in treating treatment-resistant depression. The mid-stage clinical trial, comprising 81 participants, revealed a significant reduction in
Pharmaceutical manufacturers are tasked with the critical responsibility of monitoring and reporting safety events to ensure patient safety and regulatory compliance. This process involves detecting, documenting, evaluating, reporting, and following up on adverse events, product quality complaints,
Imagine a world where the devastating effects of Alzheimer's disease can be reversed through an innovative new drug. This scenario may soon become a reality, thanks to groundbreaking research from the Centre for Addiction and Mental Health (CAMH). The study investigates the impact of GL-II-73, an
The search for effective treatments for Parkinson's disease has been long and arduous, with researchers globally dedicating countless hours to uncover potential therapies. One promising candidate, exenatide, a GLP-1 drug traditionally used to treat Type 2 diabetes, recently underwent scrutiny in
The biopharma industry is grappling with a persistent wave of layoffs as companies navigate financial constraints and strategic realignments. Despite hopes for a reprieve in 2024, the sector saw a 3% increase in layoffs compared to the previous year. This trend underscores the ongoing challenges
The latest study from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center provides compelling evidence that CAR T cell therapy does not induce secondary cancers. This finding comes from an extensive analysis of data involving over 700
